The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.
Schizophrenia and autism spectrum disorder have long been associated with elevated levels of various small phenolic molecules (SPMs). In turn, the gut microbiota (GMB) has been implicated in the kinetics of many of these analytes. Unfortunately, research into the possible relevance of GMB-mediated S...
| Publicado en: | Psychopharmacology Vol. 236; no. 5; pp. 1471 - 1490 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
May2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |